相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Sima Singh et al.
DRUG DISCOVERY TODAY (2021)
Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation
Iqra Muneer et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
H. Kuroda et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Recent Progress on NIR-II Photothermal Therapy
Yunguang Zhang et al.
FRONTIERS IN CHEMISTRY (2021)
Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review
Sergiusz Lukasiewicz et al.
CANCERS (2021)
Is There One Key Step in the Metastatic Cascade?
Antoine M. Dujon et al.
CANCERS (2021)
Mutational Landscape of Pirin and Elucidation of the Impact of Most Detrimental Missense Variants That Accelerate the Breast Cancer Pathways: A Computational Modelling Study
Muhammad Suleman et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K. Mehta et al.
NATURE CANCER (2021)
Investigating the risk of breast cancer among women exposed to chemicals: a nested case-control study using improved exposure estimates
Cecilia Videnros et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2020)
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K. G. K. Deepak et al.
PHARMACOLOGICAL RESEARCH (2020)
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
Rita Nanda et al.
JAMA ONCOLOGY (2020)
Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques
Quanbin Zhang et al.
SCIENTIFIC REPORTS (2020)
The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis
Liguang Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Mauricio A. Medina et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women
Eun Young Kim et al.
CANCER (2020)
Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care
Sima Singh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
Ryan Kolb et al.
CANCERS (2020)
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients
Lorena Incorvaia et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas
Laura Annaratone et al.
PATHOBIOLOGY (2020)
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Ashkan Shahbandi et al.
TRENDS IN CANCER (2020)
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
Luca Gianni et al.
CANCER RESEARCH (2020)
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma-Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection
Xue Wang et al.
ONCOLOGY RESEARCH AND TREATMENT (2019)
A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations
Ji-Wei Chang et al.
CARCINOGENESIS (2019)
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
Wijden Mahfoudh et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Inherited variants in XRCC2 and the risk of breast cancer
Wojciech Kluzniak et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study
Deirdre A. Hill et al.
PLOS ONE (2019)
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
Lei Nie et al.
NATURE COMMUNICATIONS (2019)
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
Wei-Siang Liao et al.
ACTA BIOMATERIALIA (2019)
Discovery of selective inhibitors for cyclic AMP response element-binding protein: a combined ligand and structure-based resources pipeline
Iqra Muneer et al.
ANTI-CANCER DRUGS (2019)
Occupational Chemical Exposure and Breast Cancer Risk According to Hormone Receptor Status: A Systematic Review
Veruscka Leso et al.
CANCERS (2019)
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index A Secondary Analysis of a Randomized Clinical Trial and Observational Study
Neil M. Iyengar et al.
JAMA ONCOLOGY (2019)
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)
Nur Zeinomar et al.
BREAST CANCER RESEARCH (2019)
Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
Qingshuo Meng et al.
ACS NANO (2018)
Dietary Patterns and Breast Cancer Risk: A Systematic Review
Akhila Dandamudi et al.
ANTICANCER RESEARCH (2018)
Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
Ruijing Liang et al.
BIOMATERIALS (2018)
Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study
Louise E. Johns et al.
BRITISH JOURNAL OF CANCER (2018)
Inference of Transcriptional Regulation from Expression Data Using Model Integration
Long Wang et al.
CURRENT BIOINFORMATICS (2018)
Breast cancer family history and allele-specific DNA methylation in the legacy girls study
Hui-Chen Wu et al.
EPIGENETICS (2018)
Prognosis and outcome in CDH1-mutant lobular breast cancer
Giovanni Corso et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2018)
The critical role of p16/Rb pathway in the inhibition of GH3 cell cycle induced by T-2 toxin
Zainab Fatima et al.
TOXICOLOGY (2018)
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort
Thibault Fiolet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort
Thibault Fiolet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer
Gabriele Corda et al.
JOURNAL OF PATHOLOGY (2017)
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
Clinton Yam et al.
ONCOLOGIST (2017)
Vitamin D and Breast Cancer: Latest Evidence and Future Steps
Manar Atoum et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2017)
Screening of medicinal plant phytochemicals as natural antagonists of p53-MDM2 interaction to reactivate p53 functioning
Muhammad Riaz et al.
ANTI-CANCER DRUGS (2017)
Predictors of distress in female breast cancer survivors: a systematic review
Ania Syrowatka et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tianjian Yu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
The paradoxical functions of EGFR during breast cancer progression
Remah Ali et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer
Hong-Mei Zheng et al.
TUMOR BIOLOGY (2016)
Alcohol Use and Breast Cancer: A Critical Review
Kevin D. Shield et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2016)
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
Jacqueline Tsai et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
Na Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Radiation therapy for breast cancer: Literature review
Karunakaran Balaji et al.
MEDICAL DOSIMETRY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Notch signaling: its roles and therapeutic potential in hematological malignancies
Yisu Gu et al.
ONCOTARGET (2016)
Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
Hmwe H. Kyu et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
Hmwe H. Kyu et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A Metabolic immune Checkpoint: Adenosine in Tumor Microenvironment
Akio Ohta
FRONTIERS IN IMMUNOLOGY (2016)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
Simon B. Zeichner et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2016)
Genetics of breast cancer: a topic in evolution
S. Shiovitz et al.
ANNALS OF ONCOLOGY (2015)
Breast cancer risk associated with benign breast disease: systematic review and meta-analysis
Sara W. Dyrstad et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Therapeutic targets of triple-negative breast cancer: a review
Vinayak S. Jamdade et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Notch signaling: An emerging therapeutic target for cancer treatment
Xun Yuan et al.
CANCER LETTERS (2015)
The effect of environmental chemicals on the tumor microenvironment
Stephanie C. Casey et al.
CARCINOGENESIS (2015)
Obesity in breast cancer - What is the risk factor?
F. R. James et al.
EUROPEAN JOURNAL OF CANCER (2015)
Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
Jessica Swanner et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
William M. Sikov et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells
Dinesh Vyas et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
Yu-Chun Hsiao et al.
ONCOTARGET (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effects of Age on the Detection and Management of Breast Cancer
Andrew McGuire et al.
CANCERS (2015)
Minimizing second cancer risk following radiotherapy: current perspectives
John Ng et al.
CANCER MANAGEMENT AND RESEARCH (2015)
Links between alcohol consumption and breast cancer: a look at the evidence
Ying Liu et al.
WOMENS HEALTH (2015)
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
J. M. Nabholtz et al.
ANNALS OF ONCOLOGY (2014)
Juxtacrine Signaling Is Inherently Noisy
Tomer Yaron et al.
BIOPHYSICAL JOURNAL (2014)
Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters
Leena Hilakivi-Clarke
BREAST CANCER RESEARCH (2014)
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study
A. Castello et al.
BRITISH JOURNAL OF CANCER (2014)
Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
Elvin Blanco et al.
MOLECULAR THERAPY (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Green tea compounds in breast cancer prevention and treatment
Min-Jing Li et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Breast cancer statistics and markers
Mallika Siva Donepudi et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Anticancer potential of phytochemicals against breast cancer: Molecular docking and simulation approach
Bilal Ahmed et al.
BANGLADESH JOURNAL OF PHARMACOLOGY (2014)
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olof Bjarnadottir et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up
Xuehong Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
FRET Enhanced Fluorescent Nanodiamonds
Rafal Fudala et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2013)
Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer
Laura Wright et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Effects of Alcohol on the Endocrine System
Nadia Rachdaoui et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2013)
The Effect of Curcumin on Breast Cancer Cells
Dongwu Liu et al.
JOURNAL OF BREAST CANCER (2013)
Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
Miguel Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
Koichiro Hayashi et al.
THERANOSTICS (2013)
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
Mike De Vos et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Targeting the Hedgehog signaling pathway for cancer therapy
Yiwei Li et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Cancer Treatment
Sook Ryun Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
Yichao Zhu et al.
PLOS ONE (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Leif W. Ellisen
CANCER CELL (2011)
The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
Suzanne A. Eccles
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
Thomas Helleday
MOLECULAR ONCOLOGY (2011)
Hormone replacement therapy and the risk of breast cancer
Steven A. Narod
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Craig A. Cooney et al.
BREAST CANCER RESEARCH (2011)
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Melinda Protani et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Xinhui Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
Sharon Nofech-Mozes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Rui Benedito et al.
CELL (2009)
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
Jiyoung Rhee et al.
BMC CANCER (2008)
The prognostic importance of triple negative breast carcinoma
Hakan Mersin et al.
BREAST (2008)
Impact of triple negative phenotype on breast cancer prognosis
Henry G. Kaplan et al.
BREAST JOURNAL (2008)
PROGNOSTIC VALUE OF TRIPLE-NEGATIVE PHENOTYPE AT THE TIME OF LOCALLY RECURRENT, CONSERVATIVELY TREATED BREAST CANCER
Rahul R. Parikh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Notch3: from subtle structural differences to functional diversity
D. Bellavia et al.
ONCOGENE (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
Genetic determinants of cancer metastasis
Don X. Nguyen et al.
NATURE REVIEWS GENETICS (2007)
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors
T. Palomero et al.
LEUKEMIA (2006)
Quantum dots for live cells, in vivo imaging, and diagnostics
X Michalet et al.
SCIENCE (2005)
Lower-category benign breast disease and the risk of invasive breast cancer
JP Wang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
S Weijzen et al.
NATURE MEDICINE (2002)
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:: an in vitro study
C Denoyelle et al.
CARCINOGENESIS (2001)
Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial
T Gilewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
